China · Delayed Price · Currency is CNY Landfar Bio-medicine Statistics
Total Valuation
SHE:000504 has a market cap or net worth of CNY 3.06 billion. The enterprise value is 3.20 billion.
| Market Cap | 3.06B |
| Enterprise Value | 3.20B |
Important Dates
The last earnings date was Wednesday, April 29, 2026.
| Earnings Date | Apr 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SHE:000504 has 330.02 million shares outstanding. The number of shares has decreased by -3.31% in one year.
| Current Share Class | 330.02M |
| Shares Outstanding | 330.02M |
| Shares Change (YoY) | -3.31% |
| Shares Change (QoQ) | +12.36% |
| Owned by Insiders (%) | 0.75% |
| Owned by Institutions (%) | 10.79% |
| Float | 219.84M |
Valuation Ratios
The trailing PE ratio is 70.49.
| PE Ratio | 70.49 |
| Forward PE | n/a |
| PS Ratio | 5.97 |
| PB Ratio | 8.30 |
| P/TBV Ratio | 14.24 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 55.81, with an EV/FCF ratio of -15.01.
| EV / Earnings | 75.95 |
| EV / Sales | 6.24 |
| EV / EBITDA | 55.81 |
| EV / EBIT | 61.80 |
| EV / FCF | -15.01 |
Financial Position
The company has a current ratio of 1.38, with a Debt / Equity ratio of 0.95.
| Current Ratio | 1.38 |
| Quick Ratio | 1.21 |
| Debt / Equity | 0.95 |
| Debt / EBITDA | 6.10 |
| Debt / FCF | -1.64 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 11.07% and return on invested capital (ROIC) is 12.94%.
| Return on Equity (ROE) | 11.07% |
| Return on Assets (ROA) | 4.00% |
| Return on Invested Capital (ROIC) | 12.94% |
| Return on Capital Employed (ROCE) | 11.22% |
| Weighted Average Cost of Capital (WACC) | 5.72% |
| Revenue Per Employee | 1.36M |
| Profits Per Employee | 111,503 |
| Employee Count | 378 |
| Asset Turnover | 0.63 |
| Inventory Turnover | 11.68 |
Taxes
In the past 12 months, SHE:000504 has paid 1.55 million in taxes.
| Income Tax | 1.55M |
| Effective Tax Rate | 4.17% |
Stock Price Statistics
The stock price has increased by +39.55% in the last 52 weeks. The beta is 0.39, so SHE:000504's price volatility has been lower than the market average.
| Beta (5Y) | 0.39 |
| 52-Week Price Change | +39.55% |
| 50-Day Moving Average | 9.70 |
| 200-Day Moving Average | 9.53 |
| Relative Strength Index (RSI) | 41.66 |
| Average Volume (20 Days) | 4,192,031 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:000504 had revenue of CNY 512.79 million and earned 42.15 million in profits. Earnings per share was 0.13.
| Revenue | 512.79M |
| Gross Profit | 101.62M |
| Operating Income | 51.80M |
| Pretax Income | 37.20M |
| Net Income | 42.15M |
| EBITDA | 56.90M |
| EBIT | 51.80M |
| Earnings Per Share (EPS) | 0.13 |
Balance Sheet
The company has 303.37 million in cash and 349.68 million in debt, with a net cash position of -46.31 million or -0.14 per share.
| Cash & Cash Equivalents | 303.37M |
| Total Debt | 349.68M |
| Net Cash | -46.31M |
| Net Cash Per Share | -0.14 |
| Equity (Book Value) | 369.07M |
| Book Value Per Share | 0.84 |
| Working Capital | 212.29M |
Cash Flow
In the last 12 months, operating cash flow was -205.61 million and capital expenditures -7.68 million, giving a free cash flow of -213.30 million.
| Operating Cash Flow | -205.61M |
| Capital Expenditures | -7.68M |
| Depreciation & Amortization | 5.10M |
| Net Borrowing | -15.72M |
| Free Cash Flow | -213.30M |
| FCF Per Share | -0.65 |
Margins
Gross margin is 19.82%, with operating and profit margins of 10.10% and 8.22%.
| Gross Margin | 19.82% |
| Operating Margin | 10.10% |
| Pretax Margin | 7.26% |
| Profit Margin | 8.22% |
| EBITDA Margin | 11.10% |
| EBIT Margin | 10.10% |
| FCF Margin | n/a |
Dividends & Yields
SHE:000504 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 7.19% |
| Buyback Yield | 3.31% |
| Shareholder Yield | 3.31% |
| Earnings Yield | 1.38% |
| FCF Yield | -6.96% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on January 15, 2007. It was a forward split with a ratio of 1.3.
| Last Split Date | Jan 15, 2007 |
| Split Type | Forward |
| Split Ratio | 1.3 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |